Neuro-Cells therapy improves motor outcomes and suppresses inflammation during experimental syndrome of amyotrophic lateral sclerosis in mice.
Johannes P J M de MunterIgor ShafarevichAleksey V LyundupDmitrii PavlovErik Ch WoltersAnna GorlovaEkaterina VeniaminovaAleksei UmriukhinAllan V KalueffAndrei SvistunovBoris W KramerKlaus-Peter LeschTatyana StrekalovaPublished in: CNS neuroscience & therapeutics (2019)
The neuropathology in FUS-tg mice is sensitive to standard ALS treatments and Neuro-Cells infusion. The latter improves motor outcomes in two ALS models possibly by suppressing microglial activation.